Efficacy and Safety of Ravidasvir in Combination With Danoprevir/r and Ribavirin(RBV) in Treatment-naive, Non-cirrhotic, Chronic Hepatitis C Virus Genotype1 Infected Subjects.
Clinical trial NCT03362814 · COMPLETED
Trial details
- NCT number
- NCT03362814
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2018-12-12
- Enrollment
- 425
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.